2017
DOI: 10.1159/000485252
|View full text |Cite
|
Sign up to set email alerts
|

Hypertensive Cerebral Hemorrhage in a Patient with Turner Syndrome Caused by Deletion in the Short Arm of the X Chromosome

Abstract: Turner syndrome is a chromosomal disorder usually caused by complete deletion of an X chromosome, with deletion in the short arm of the X chromosome being a rare cause of the condition. Patients with Turner syndrome commonly develop hypertension, and associated vascular complications such as aortic dissection or cerebral hemorrhage have been reported. Cerebral hemorrhage in Turner syndrome is a rare complication, and only a few reports have been published. In these reports, all patients have XO karyotypes or a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…A recent study from Denmark found that use of hormone replacement therapy among patients with TS was associated with a lower risk of hypertension and ischemic stroke, suggesting a role of estrogen deficiency in the pathogenesis of impaired metabolic profile and cardiovascular complications (Viuff et al, 2020). However, hemorrhagic stroke has been described only in case reports and was not discussed in the recent guidelines (Gravholt et al, 2017; Hori et al, 2018; Manjila et al, 2014; Silberbach et al, 2018). The results of the current study may serve as a reminder to clinicians that the risk of hemorrhagic stroke is also heightened in this group of patients.…”
Section: Discussionmentioning
confidence: 99%
“…A recent study from Denmark found that use of hormone replacement therapy among patients with TS was associated with a lower risk of hypertension and ischemic stroke, suggesting a role of estrogen deficiency in the pathogenesis of impaired metabolic profile and cardiovascular complications (Viuff et al, 2020). However, hemorrhagic stroke has been described only in case reports and was not discussed in the recent guidelines (Gravholt et al, 2017; Hori et al, 2018; Manjila et al, 2014; Silberbach et al, 2018). The results of the current study may serve as a reminder to clinicians that the risk of hemorrhagic stroke is also heightened in this group of patients.…”
Section: Discussionmentioning
confidence: 99%